References
- Bagley C. M., Jr., Young R. C., Canellos G. P., De Vita V. T. “Treatment of Ovarian Carcinoma: Possibilities for Progress,”. N. Engl. J. Med. 1972; 287: 856–862
- Sullivan R. D., et al. “Reevaluation of Methotrexate as an Anticancer Drug,”. Surg. Gynecol. Obstet 1967; 125: 819–624
- Hryniuk W. M., Bertino J. R. “Treatment of Leukemia with Large Doses of Methotrexate and Folinic Acid: Clinical-Biochemical Correlates,”. J. Clin. Invest 1969; 48: 2140–2155
- Hryniuk W. M., et al. “Consequence of Methotrexate Inhibition of Purine Synthesis in L5178Y Cells,”. Cancer Res 1975; 35: 1427–1432
- Chabner B. A., Young R. C. “Threshold Methotrexate Concentration for in vivo Inhibition of DNA Synthesis in Normal and Tumorous Tissues,”. J. Clin. Invest 1973; 52: 1804–1811
- Young R. C., Rosenoff S. A., Myers C. E., Brereton H., Chabner B. A. “Alterations in DNA Synthesis Induced by Chemotherapy Agents in vivo: Potential Applications to Clinical Treatment Schedules,”. Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells, B. Drewinko, R. M. Humphrey. Williams and Wilkins, Baltimore 1977
- Zaharko D. S., Dedrick R. L. “Antifolates: In vivo Kinetic Considerations,”. Cancer Treat. Rep. 1977; 61: 513–518
- Myers C., Jones R., Londer H., Hubbard S., Brennan M., Balow J., Dedrick R., Ozols R., De Vita V. “Pharmacology of High-Dose Methotrexate Administered via Peritoneal Dialysis,”. in Proceedings of the 14th Annual Meeting of the American Society of Clinical Oncology, April 1978 1978; 19: 390
- Djerassi I., et al. “Continuous Infusion of Methotrexate in Children with Acute Leukemia,”. Cancer 1967; 20: 233–242
- Jaffe N., et al. “Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic Sarcoma,”. N. Engl. J. Med. 1974; 291: 994–997
- Von Hoff D. D., et al. “The Incidence of Drug Related Deaths Secondary to High Dose Methotrexate (NSC-740),”. Cancer Treat. Rep. 1977; 61: 745–748
- Stoller R. G., Hande K. R., Jacobs S. A., Rosenberg S. A., Chabner B. A. “Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity,”. N. Engl. J. Med. 1977; 297: 630–634
- Jacobs S. A., et al. “7-Hydroxymethotrexate as a Urinary Metabolite in Human Subjects and Rhesus Monkeys Receiving High Dose Methotrexate,”. J. Clin. Invest 1976; 57: 534–538
- Jacobs S. A., Stoller R. G., Chabner B. A., Johns D. G. “Dose-Dependent Metabolism of Methotrexate in Man and Rhesus Monkey,”. Cancer Treat. Rep. 1977; 61: 651–656